{"cik":1827855,"entityName":"Medicale Corp.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2020-12-31","val":3400000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":5920000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"EntityListingParValuePerShare":{"label":"Entity Listing, Par Value Per Share","description":"The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0.0001,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"}],"USD/shares":[{"start":"2020-10-01","end":"2021-03-31","val":0.0001,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2018-12-31","val":12000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":12000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":12000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":12000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"AccountsReceivableNetCurrent":{"label":"Accounts Receivable, after Allowance for Credit Loss, Current","description":"Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.","units":{"USD":[{"end":"2018-12-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"AccretionExpense":{"label":"Accretion Expense","description":"Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":3000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":6000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2018-12-31","val":603,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":603,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":8517,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":10792,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2018-12-31","val":180,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":180,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":180,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":25128,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2018-12-31","val":12200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":12200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":11600,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":34900,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2018-12-31","val":200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":24100,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-09-30","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01"},{"end":"2020-09-30","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":23900,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsPeriodIncreaseDecrease":{"label":"Cash and Cash Equivalents, Period Increase (Decrease)","description":"Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":23900,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD":[{"end":"2020-09-30","val":0.0001,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0.0001,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"}],"USD/shares":[{"end":"2020-09-30","val":0.0001,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2020Q3I"},{"end":"2021-03-31","val":0.0001,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-09-30","val":75000000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01"},{"end":"2020-09-30","val":75000000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2020Q3I"},{"end":"2020-12-31","val":75000000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":75000000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":3400000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":5920000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":3400000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":5920000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":600,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":1200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"DueFromRelatedParties":{"label":"Due from Related Parties","description":"For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.","units":{"USD":[{"end":"2018-12-31","val":200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":24100,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"}],"USD/shares":[{"start":"2020-10-01","end":"2021-03-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"FiniteLivedIntangibleAssetsNet":{"label":"Finite-Lived Intangible Assets, Net","description":"Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2018-12-31","val":12000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":12000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":11400,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":10800,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":-11514,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":-18689,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2018-12-31","val":12200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":12200,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":11600,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":34900,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2018-12-31","val":13603,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":13603,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":24517,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":29792,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":7914,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":35389,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":-7914,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":-11489,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":-11514,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":-18689,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":-11514,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":-18689,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":25200,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"ProceedsFromRelatedPartyDebt":{"label":"Proceeds from Related Party Debt","description":"The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":7914,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":10189,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"ProfessionalFees":{"label":"Professional Fees","description":"A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":11514,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":18689,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":-11514,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":-18689,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2018-12-31","val":-1923,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":-1923,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-13437,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-20612,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"Revenues":{"label":"Revenues","description":"Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":0,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}},"ShortTermBorrowings":{"label":"Short-term Debt","description":"Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2018-12-31","val":1000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":1000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":4000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":7000,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2018-12-31","val":-1403,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2018Q4I"},{"end":"2020-09-30","val":-1403,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-12917,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":5108,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12","frame":"CY2021Q1I"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-10-01","end":"2020-12-31","val":3400000,"accn":"0001827855-21-000003","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-02-01","frame":"CY2020Q4"},{"start":"2020-10-01","end":"2021-03-31","val":3803515,"accn":"0001827855-21-000006","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-05-12"}]}}}}}